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A simple visual assay is described for determining the capacity of bovine serum to neutralize the cytotoxin
produced by Pasteurella haemolytica serotype 1. The test was reproducible from day to day with different target
cell populations and cytotoxin preparations. Cytotoxin neutralization titers obtained by the visual assay were
comparable to those determined by the trypan blue exclusion and 51Cr-release methods. The visual assay was
used to measure neutralization titers of bovine sera obtained from vaccination experiments and fractions of
purified serum obtained by gel filtration. The major advantages of the visual assay over other assays are that
it is rapid, inexpensive, and does not use radioisotopes. It also does not require specialized equipment, making
it adaptable to most laboratories.
Pasteurella haemolytica serotype 1, the bacterium most
commonly associated with the severe fibrinous pneumonia
of shipping fever (pneumonic pasteurellosis) in cattle, pro-
duces a cytotoxin which is toxic for bovine pulmonary
alveolar macrophages (3, 13) and peripheral blood leuko-
cytes (4, 11). Cytotoxic effects of the organism on
phagocytes may contribute to the severity of lung lesions
seen in shipping fever (11, 12); thus, cytotoxin may play an
important role in the pathogenesis of the disease (18).
P. haemolytica cytotoxin is immunogenic, and it has been
proposed as a potential immunizing agent for cattle (10).
Neither fetal bovine serum nor serum from colostrum-
deprived newborn calves neutralizes the effects of cytotoxin
on bovine peripheral blood leukocytes (2, 6, 9). However,
cytotoxin-neutralizing (CN) antibodies have been demon-
strated in sera from immunized rabbits (19), adult bovine
sera (2, 6, 20), bovine nasal secretions and lung washings (6),
and bronchoalveolar washings from experimentally vacci-
nated calves (J. Opudo-Asibo, E. L. Townsend, S. K.
Maheswaran, and J. R. Leninger, Abstr. N. Am. Symp.
Bovine Respir. Dis., 1983). In recent retrospective studies,
the capacity of cattle sera to neutralize cytotoxin was
correlated with development of fibrinous pneumonia and
survival from naturally occurring disease (6, 20). In studies
in our laboratory, CN titers determined by testing serial
dilutions of cattle sera correlated directly with resistance of
animals to a transthoracic, intrapulmonic challenge with live
organisms (9). High antibody titers to somatic antigens in
sera from the same animals did not correlate with resistance.
Therefore, it appears that determination of the serum CN
capacity of a calf may be an important indication of its
relative resistance to pneumonic pasteurellosis.
Serum cytotoxin neutralization studies are performed with
assays that quantitate killing of cells exposed to cytotoxin
which has been preincubated with serial dilutions of serum.
The trypan blue exclusion method used by Gentry et al. (9)
is labor intensive and requires staggered incubation of sam-
ples, because each one must be counted individually. This
limits the number of sera which can be processed in 1 day.
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Cho et al. (6) and Shewen and Wilkie (20) used 51Cr-release
methods to determine CN titers. The 51Cr-release assay
system allows concurrent incubation and harvesting of many
samples. However, triplicate or quadruplicate sampling
techniques are recommended, and laboratories using the
method must have a gamma counter and be licensed to use
radioisotopes.
Recently, an automated colorimetric assay performed in
flat-bottomed microtiter plates was reported (C. N. Greer
and P. E. Shewen, Annu. Meet. Conf. Res. Workers Anim.
Dis., abstr. no. 154, 1984). This assay is based on the
assumption that only viable cells are stained by the dye
neutral red. It is used to estimate cell survival after exposure
to cytotoxin by spectrophotometric measurement of the
quantity of neutral red released by solubilization of treated,
stained, and washed cell monolayers. This assay is rapid and
does not use radioisotopes but does require a spectropho-
tometer equipped to read microtiter plate wells. Preincuba-
tion of cytotoxin and serum also had to be performed in
separate tubes.
Direct assays of antibody to cytotoxin are not available,
because crude cytotoxin contains numerous P. haemolytica
antigens. Attempts to purify the cytotoxin have resulted in
various estimates of its molecular weight and often have
resulted in loss of toxicity (2, 10). Until a more purified
product becomes available, it is particularly important to
have a practical assay for determination of CN titers. The
visual CN assay presented herein is rapid, simple, and
inexpensive. It requires no specialized equipment for viabil-
ity measurement and allows six sera to be diluted and tested
within a single 96-well microtiter plate.
MATERIALS AND METHODS
Cytotoxin preparation. The cytotoxins used were prepared
by the method of Shewen and Wilkie (18). Briefly, P.
haemolytica biotype A serotype 1 organisms grown to
logarithmic phase in brain heart infusion broth were
incubated for 1 h at 37°C in RPMI 1640 medium supplemented
with 7% fetal bovine serum. The culture was then centrifuged
(13,500 x g for 15 min), and the supernatant was filter
sterilized and lyophilized. Protein concentrations determined
by the dye-binding assay of Bradford (5) with commercially
prepared reagents (Bio-Rad Laboratories, Richmond, Calif.)
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ranged from 0.36 to 0.48 mg of protein per ml for different
cytotoxin lots.
Extinction endpoints determined as described below were
used to standardize cytotoxin preparations. Only those lots
having an extinction endpoint of 1/64 were used in the assay.
Antisera used. Bovine sera were collected from calves
which had been used in seven different vaccination trials
conducted in our laboratory (7, 8, 15). At a 7-day interval,
the calves had received two vaccinations of (i) phosphate-
buffered saline (PBS), (ii) live P. haemolytica organisms, or
(iii) a P. haemolytica bacterin. Blood was collected 14 days
after the second immunization. Control serum without anti-
bodies to P. haemolytica was obtained from a newborn calf
before suckling and was designated colostrum-deprived calf
serum (CDCS). All sera were heat inactivated (56°C, 30
min).
Leukocyte preparations. Heparinized blood was collected
from healthy donor calves. Mixed peripheral blood leuko-
cytes (MPBL) were separated from erythrocytes by
hypotonic lysis with distilled water followed by the addition
of double-strength PBS (14). The MPBL were collected by
centrifugation (700 x g for 20 min), the pellets from several
tubes were combined, and the lysis procedure was repeated.
The final cell pellets were pooled, washed twice with PBS,
and suspended in RPMI 1640 to a final concentration of 107
cells per ml.
When peripheral blood polymorphonuclear leukocytes
(PMNL) were used, they were prepared by differential
centrifugation on Ficoll-Paque (Pharmacia, Inc.,
Piscataway, N.J.) followed by hypotonic lysis of the eryth-
rocyte-PMNL pellets and processing of the PMNL as de-
scribed above to yield a final cell suspension in RPMI 1640 of
107 cells per ml.
For several experiments, cells were labeled with 5"Cr by
suspension of 107 cells per ml in RPMI 1640 containing 50,uCi
of Na2[5lCr]O4 per ml in normal saline (ICN Pharmaceuticals
Inc., Irvine, Calif.). The cells were incubated for 1 h at 37°C
in a shaker bath, washed 3 times in PBS, and suspended in
RPMI 1640 to a concentration of 107 cells per ml.
Trypan blue exclusion CN assay. All CN assays performed
by trypan blue exclusion used PMNL as target cells. Sera to
be tested were diluted in PBS by serial twofold dilutions, and
all serum dilutions were tested for their CN ability by a
previously described method (9). Briefly, 200 ,il of lyophi-
lized cytotoxin reconstituted at 1.5x concentration was
added to 100 ,ul of a given serum dilution. The mixture was
incubated at 37°C for 10 min before being added to a PMNL
suspension in a siliconized glass tube. Cells were incubated
with the serum-cytotoxin mixture for 1 h at 37°C and then
examined in a hemacytometer for ability to exclude trypan
blue dye. A protection index, which accounted for daily
variations in controls, was calculated for each serum dilu-
tion, and the CN titer for a serum was defined as the
reciprocal of the highest dilution affording a protection index
of at least 0.80.
Visual CN assay. The assay was performed in 350-,ul well
capacity, round bottomed, 96-well tissue culture plates (Cell
Wells; Corning Glass Works, Corning, N.Y.). Twofold serial
dilutions of sera to be tested were made directly in the plates
as follows. PBS (65 ,ul) was added to each well of the plate
except the first four wells of row H, which were reserved for
controls. Serum samples (65 ,ul) were added to duplicate
wells of row A. A digital 12-channel micropipette (Titertek;
Flow Laboratories, Inc., McLean, Va.) was then used to
mix the well contents in row A and transfer 65 ,ul to the wells
in row B, then row C, etc. In this way, serial dilutions were
simultaneously performed on six sera in duplicate. Sixty-five
microliters was discarded from the final well in each dilution
series. To the four control wells (wells 1 to 4 of row H), 65
,ul of CDCS was added.
Cytotoxin (135 ,ul) reconstituted at 1.5x concentration
was added to all wells except wells 1 and 2 of row H, to
which was added 135 ,ul of RPMI 1640. The plate was
incubated for 10 min at room temperature, and then 100 ,ul of
a suspension of target cells (107 cells per ml in RPMI 1640)
was added to each well. The plate was incubated for 1 h at
37°C in 5% C02 and then centrifuged for 10 min at 200 x g.
The supernatant was removed by inverting and sharply
flicking the plate. The cell pellets were fixed for 30 min with
100 ,ul of 10% Formalin per well, stained for 5 min with 150
,ul of 1% aqueous crystal violet per well, rinsed under
running tap water, and patted dry.
Interpretation of results was made by visual examination
for the presence of a purple cell layer in the bottom of each
well. An intact cell layer, indicating CN, was scored as a
positive result, whereas complete absence of a cell layer or
presence of only a cell layer remnant, indicating toxicity,
was scored as a negative result. Wells 1 and 2 of row H
served as a positive control, and wells 3 and 4 of row H
served as a negative control. The CN titer of the serum was
defined as the reciprocal of the serum dilution contained in
the last positively scored wells. In rare cases in which
duplicate samples were scored differently, the higher of the
two titers was recorded.
-5Cr-release CN assay. This assay was performed exactly
like the visual assay with the following modifications. (i)
51Cr-labeled target cells were used; (ii) after centrifugation of
the plate, 200 ,ul of supernatant was transferred from each
well to a plastic tube for counting in an automated gamma
counter (Searle Analytical Co.); and (iii) a third set of control
wells was added, which contained 65 ,ul of PBS and 135 pl of
cytotoxin. A visual assay was sometimes performed on the
same plate by addition of 100 ,ul of 10% Formalin to the
remaining supernatant in each well. Fixation of the cell
pellets was then allowed to continue overnight before stain-
ing of the plate as described previously.
Calculation of percent killing and the protection index was
performed according to the following formulas: percent
killing = ([counts per minute of test sample - counts per
minute of PBS negative control]/[counts per minute of pos-
itive control - counts per minute of PBS negative control])
x 100; and PI = (percent killing with CDCS - percent killing
with test serum)/percent killing with CDCS.
Determination of cytotoxin extinction endpoint. Serial two-
fold dilutions in RPMI 1640 were prepared of Iyophilized
cytotoxin samples which had been reconstituted at 1.5x
with distilled water. Diluted cytotoxin samples (135 ,tl) were
added to duplicate wells of a 96-well microtiter plate. To
simulate the condition of a CN assay, we added 65 pul of a
10% solution of CDCS in PBS to each well. The plate was
incubated for 10 min at room temperature, 100 ,ul of a target
cell suspension was added to each well, and the plate was
then processed exactly as it would have been for a "Cr-
release or a visual CN assay or both. The cytotoxin extinc-
tion endpoint was defined as the highest cytotoxin dilution
causing 51Cr release of at least 60% of maximum or the
highest dilution contained in the last positively scored wells
of a visual assay.
Comparison of visual CN titers with resistance. Visual CN
titers performed on 40 sera from cattle used in vaccination
experiments were compared by linear regression analysis (1)
with lesion scores calculated for the calves as previously
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described (16). Briefly, lesion scores ranging from 0 to 20
were ascribed to each animal according to specific morpho-
logical parameters of the lung lesions induced by a
transthoracic, intrapulmonic challenge with live P.
haemolytica. The higher the lesion score, the more suscep-
tible the calf was to the challenge.
Testing of CN capacity of serum fractions. We fractionated
serum from a steer hyperimmunized with live P. haemolyti-
ca on an Ultrogel-ACA 34 gel filtration column (LKB
Instruments, Inc., Rockville, Md.) to obtain purified immu-
noglobulin. Duplicate 65-,idl samples of serum fractions were
tested for CN capacity by a standard 5tCr-release assay
followed by visual staining of the remaining cell pellets.
Percent specific release of 51Cr from the cells was calcqlated
by the following formula: percent specific release = ([counts
per minute of test sample - counts per minute of negative
control]/[counts per minute of positive control - counts per
minute of negative control]) x 100, where negative control =
wells containing 65 ,uI of CDCS + 135 ,ul of cytotoxin and
positive control = wells containing 65 mI of CDCS + 135 ,ul
of RPMI 1640.
Statistical analysis. Comparison of mean lesion scores and
CN titers for groups of animals divided according to vacci-
nation treatments were made with a multiple t test by the
least-square-difference procedure (17). Reproducibility of
the visual CN assay performed on the same sera on different
days was evaluated by analysis of variance of the natural
logarithms of mean daily titers (17).
RESULTS
Comparison of visual, trypan blue, and 5tCr-release assays.
To date, visual CN titers have been performed in our
laboratory on 86 sera from calves which have been used in
vaccination trials. The titers determined on these sera have
ranged from <2 to >512, with the vast majority being in the
range of 2 to 128 (Fig. 1). CN titers for 11 sera were
compared by visual, trypan blue exclusion, and 5`Cr-release
assays (Table 1). Although titers were determined by the
three methods on different target cell populations on sepa-
FIG. 1. Stained plate used in a CN assay. Six sera were assayed
in duplicate in dilutions ranging from 1/2 in row A to 1/256 in row H.
Dark wells contained intact cell layers and were scored positively,
whereas light wells indicated disrupted cell layers and were scored
negatively. The CN titers thus determined for the six sera repre-
sented were 32, 8, 2, 32, <2, and 16, respectively. Wells Hi and H2
served as positive controls, and wells H3 and H4 served as negative
controls.
TABLE 1. Comparison of three CN assays
CN titer determined by:
Antiserum no. Trypan blue 5tCr release Visual
exclusion C ees assayb
1 32 32 64
2 16 16 32
3 32 64 64
4 128 128 64
5 64 64 128
6 8 4 8
7 16 16 32
8 64 32 64
9 16 16 32
10 32 16 32
il 32 16 32
a CN titer is expressed as the reciprocal of the highest serum dilution
affording a protection index >0.80.
b CN titer is expressed as the reciprocal of the highest serum dilution
contained in the last positively scored wells.
rate days, they never varied by more than 1 dilution for any
given serum. The trypan blue result was 1 dilution lower
than the other two for 1 of the 11 sera. The 51Cr-release
result was 1 dilution lower than the other two for 4 of the
sera. The visual assay result was 1 dilution lower for one
serum and 1 dilution higher for five sera than those of the
other two methods. Titers determined for 17 additional sera
by visual and 51Cr-release assays performed on the same
plates correlated perfectly (data not shown).
Reproducibility of visual assay. To examine the reproduc-
ibility of the assay system, we determined CN titers by the
visual assay five different times for the same 12 sera (Table
2). The trials were performed on four separate days with
targèt cells from three different animals. For 5 of the 12 sera,
all five trials resulted in the same titèr. For four sera, four of
the five trials were in agreement. For the three additional
sera, three of the five trials agreed, with the remaining titers
in each case being 1 dilution higher or lower. The results did
not differ significantly from day to day (P = 0.25).
Variation of target cell population. Titers of eight sera were
identical when determined simultaneously with MPBL or
TABLE 2. Reproducibility of the visual CN assay on different
days and with different target cell preparations
Antiserum CN titerb determined for trial no.: No. of trials
no. 1 2 3 4 5 in agreement
576 128 128 128 128 128 5
581 16 16 16 16 8 4
583 32 32 32 32 32 5
584 8 8 8 8 8 5
585 4 4 8 8 4 3
587 32 32 32 16 16 3
588 2 2 2 4 2 4
601 64 32 64 64 32 3
604 4 4 4 4 4 5
627 16 32 16 16 16 4
630 2 2 2 2 2 5
632 128 128 128 64 128 4
a Assays were performed on four separate days with MPBL from three
different target cell donors. The mean titers in trials 1 through 5 were 36.3,
35.0, 36.7, 30.2, and 31.7, respectively, and they did not differ significantly (P
= 0.25).
b Titer is expressed as the reciprocal of the highest serum dilution contained
in the last positively scored wells.
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PMNL from the same animal as the target cells. For such
paired assays, however, the stain intensity was greater and
results were more easily interpreted when PMNL were used.
There was also an obvious difference in intensity of staining
when cells from different animals were used. These varia-
tions could not be related to differences in initial viability or
differential cell count of the target cell preparations (data not
shown) and were found to be consistent for given animals on
a day-to-day basis. Attempts to use target cells at concen-
trations of <107 cells per ml resulted in inadequate staining
with MPBL from certain animals.
Variations in cytotoxin preparations. Use of cytotoxin
preparations which had been reconstituted at concentrations
<1.5x (allowing a final concentration of <lx in the test
wells) resulted in increased titers for certain sera. To deter-
mine the effect of using different lots of lyophilized cytotoxin
on CN titers, we performed assays for three sera with
cytotoxin samples prepared in our laboratory on six different
days in 10 separate lots (Table 3). With 9 of the 10 cytotoxin
preparations, the titers obtained for each of the sera agreed
within 1 dilution. Cytotoxin B was apparently less toxic,
allowing each of the sera to neutralize at two- to threefold
higher dilutions. The differences in titers of the three sera
when tested with various cytotoxin lots were also reflected
in a comparison of their extinction endpoints and protein
concentrations (Table 3). Comparable extinction endpoints
were obtained by the 5"Cr-release and visual assay methods
for five lots of cytotoxin tested by both procedures.
Applications of the visual CN assay. CN titers were deter-
mined by the visual assay for sera from 40 calves from three
experimental groups having significantly different (P =
0.0001) degrees of resistance to a live P. haemolytica chal-
lenge as measured by lesion score (Table 4). Linear regres-
sion analysis of lesion score versus the natural logarithm of
the CN titer for all 40 animals had a correlation coefficient of
-0.5887 (P < 0.001). At the 0.05 confidence level, the group
of animals receiving live vaccine had significantly higher CN
titers than did the PBS control group or the group receiving
bacterins. The CN titers of bacterin-treated animals did not
differ significantly from those of the PBS-treated control
group.
The visual CN and 51Cr-release assays were used to screen
TABLE 3. Reproducibility of the visual CN assay with different
preparations of cytotoxin
CN titer" of serum fo.:Cytotoxinm ________of______no. Extinction Protein concn
prepna 1 2 3 endpointc (mg/ml)d
A 2 16 32 1/64 0.46
B 8 64 128 1/16 0.36
C 2 16 32 1/64 0.42
D 4 32 64 1/32 0.37
E 2 16 32 1/128 NTe
F 4 32 64 1/32 0.43
G 4 32 64 1/32 NT
H 4 16 64 1/32 0.42
I 4 16 64 1/32 NT
J 2 16 64 1/64 0.48
a Cytotoxin preparations prepared by the same method on different days.b Titer is expressed as the reciprocal of the highest serum dilution contained
in the last positively scored wells.
c Extinction endpoint as determined by 51Cr-release or visual assay or both.
Endpoints are expressed as the highest dilution of cytotoxin causing at least
60%o of maximum 5"Cr release or the highest dilution contained in the last
positively scored wells of a visual assay.
d Determined by the method of Bradford (5).
e NT, Not tested.
TABLE 4. Mean CN titers, as measured by the visual assay, for
calves from vaccination trials
Treatment No. of Mean visual Lesion
groupa animals CN titerb scored
PBS 14 4.8 + 2.1 15.7 + 5.1
Bacterin 13 7.9 + 2.3 13.4 ± 7.6
Live vaccine 13 70.2 ± 1.7 4.1 ± 1.9
a Animals received two injections at a 1-week interval of PBS, a commercial
P. multocida and P. haemolytica bacterin containing an AI (OH)3 adjuvant, or
a live culture of P. haemolytica containing 5 x 109 CFU.
b Values represent means ± standard deviations.
serum fractions for neutralizing capacity (Fig. 2). All frac-
tions affording a percent specific release of greater than 40%
were negative by visual assay, whereas all fractions allowing
a percent specific 5"Cr release of less than 40% were visual
assay positive. In similar experiments, a positive visual
assay has correlated with percent specific releases ranging
from 20 to 35% (data not shown).
DISCUSSION
The visual CN assay described herein tests the capacity of
bovine serum to neutralize P. haemolytica cytotoxin. Re-
sults with this assay were comparable to those obtained by
both the trypan blue exclusion and `1Cr-release assays. The
advantages of the visual CN assay over trypan blue exclu-
sion are that it is less labor intensive and more sera can be
tested at one time. The visual assay also has several advan-
tages over 51Cr release, including decreased time involved
and the use of duplicate rather than triplicate samples. Most
important, the visual assay does not require the use of
radioisotopes, which includes such considerations as ex-
pense, safety, and disposal of radioactive wastes, as well as
the requirement for a gamma counter. Additional advantages
of the visual CN assay are that it requires no specialized
equipment, making it adaptable to most laboratories, and
permanent records of results may be made by photocopying
stained plates.
The visual CN assay has been shown to be reproducible
when care is taken to standardize the cytotoxin preparation
used. This may be accomplished by performing an endpoint
titration of each lot of cytotoxin used in the assay. Although
comparable extinction endpoints were obtained with the
51Cr-release and visual assay procedures, use of the 51Cr-
release assay is recommended for determining cytotoxin
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FIG. 2. Comparison of the visual and 5tCr-release assays for
detection of CN capacity of serum fractions. A positive visual assay
correlated with a percent specific "tCr release of 40%. Fractions 54
to 72 were designated for pooling on the basis of each assay.
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sometimes impossible. In those cases, stainable cell layers
were not formed, even at cytotoxin dilutions which did not
cause release of 5'Cr from the cells. This phenomenon may
be due to cytoplasmic membrane damage by nonlethal
cytotoxin concentrations, preventing adherence, and thus
cell layer formation, by viable target cells.
To ensure more consistent results from day to day in our
laboratory, we prepare and lyophilize 2-liter volumes of
cytotoxin at one time, and then store them at 4°C for
subsequent use. Only those preparations having an extinc-
tion endpoint of 1/64 are used. Lots with other endpoints
may be used after appropriate dilution or concentration.
The test is applicable for assaying neutralization of
cytotoxin with either PMNL or MPBL. The increased inten-
sity of staining with PMNL is most likely due to the higher
percentage of cells that can attach to plastic and thus be less
easily dislodged from the plate during the fixation and
staining procedures. The disadvantages of using PMNL
rather than MPBL are the cost of the Ficoll-Paque required
and additional time needed for their isolation. Although the
results obtained with target cells from different animals were
comparable, we found that cells from certain donor calves
consistently provided more intense staining than those from
other calves. We were unable to explain these differences on
the basis of initial viability or differential cell counts, but we
did observe that cells derived from readily excitable animals
were less likely to stain intensely. This phenomenon may be
due to induction of increased levels of corticosteroids in
excitable animals during the blood collection procedure.
Administration of glucocorticoids in man has been shown to
decrease the adherence properties of neutrophils (16).
The CN titer of the serum of an animal may be used as an
indicator of its relative resistance to a live P. haemolytica
challenge. A comparison by linear regression analysis of sera
from 40 animals in three experimental groups with their
resistance to experimental challenge as indicated by their
postchallenge lesion scores showed a highly significant neg-
ative correlation. Thus, the greater the CN titer of the serum
of an animal, the more resistant it was likely to be to a
challenge with live organisms. CN titers also have been
shown to be more reliable than titers of serum to somatic
antigens as an indicator of prior exposure to the organism
(10). We are currently using the visual CN assay as one of
our criteria to determine the previous exposure of an animal
to P. haemolytica and to measure the efficacy of experimen-
tal vaccines.
The visual CN assay also may be used as a screening tool
when purifying immunoglobulin from serum collected from
an immunized animal. In several trials, the visual assay
identified all serum fractions affording at least a 60 to 80%
reduction in cytotoxin activity, making it essentially as
sensitive as the 5tCr-release assay for identifying fractions
with CN capabilities. In conclusion, the visual CN assay is a
simple, rapid, inexpensive, and reliable test for determina-
tion of P. haemolytica CN titers of cattle sera.
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